Asahi Intecc Co Ltd 最近的每股盈餘為 $30.16,超出預期 $23.9 的預期。
Asahi Intecc Co Ltd AICLY 上一季度的收入表現如何?
Asahi Intecc Co Ltd 上一季度的收入為 $30.16
Asahi Intecc Co Ltd 的收入預期是多少?
根據 9 位華爾街分析師的預測,Asahi Intecc Co Ltd 的收入預期範圍從 $37.48B 到 $32.06B
Asahi Intecc Co Ltd 的盈利品質評分是多少?
Asahi Intecc Co Ltd 的盈利品質評分為 /。該評分基於盈利能力、增長、現金生成與資本分配以及槓桿四個維度。
Asahi Intecc Co Ltd 何時發布財報?
Asahi Intecc Co Ltd 的下一份財報預計在 2026-05-14 發布
Asahi Intecc Co Ltd 的預期收益是多少?
根據華爾街分析師的預測,Asahi Intecc Co Ltd 的預期收益為 $32.8B
Asahi Intecc Co Ltd 是否超出收益預期?
Asahi Intecc Co Ltd 最近的收益為 $35.2B,超出預期 預期。
關鍵數據
前收市價
$18.7
開盤價
$18.7
當日範圍
$18.7 - $18.7
52週區間
$18.7 - $18.7
交易量
--
平均成交量
400
股息收益率
--
每股盈餘 (TTM)
--
市值
$5.0B
什麼是 AICLY?
Asahi Intecc Co., Ltd. engages in the development, manufacture, and sale of medical and industrial equipment products. The company is headquartered in Seto-Shi, Aichi-Ken and currently employs 9,473 full-time employees. The company went IPO on 2004-07-01. The company operates through two business segments. The Medical Business segment develops and manufactures minimally invasive treatment products (treatment guidewires and catheters) primarily used for intravascular treatment and sells them to hospitals and other facilities primarily through direct sales in Japan, mostly through distributors in overseas, and primarily through direct sales in the United States, France, Germany, and Italy. The Device Business segment develops and manufactures components for the medical and industrial equipment fields and sells them to manufacturers both in Japan and overseas. Products are used as medical equipment in areas such as circulatory system, abdominal, peripheral and cerebrovascular systems, as well as industrial equipment in a wide range of fields, including leisure, construction and automobiles.